[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341248-105":59,"doc-detail-341248-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ceacam6-expression-and-function-in-tumor-biology-a-comprehensive-review","CEACAM6 expression and function in tumor biology - a comprehensive review","","Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) is an immunoglobulin superfamily protein expressed on epithelial surfaces and myeloid cells. CEACAM6 drives cancer progression by inhibiting apoptosis, promoting drug resistance, and enabling invasion and metastasis. Overexpression occurs across lung, breast, colorectal, and hepatocellular cancers and correlates with worse overall and disease-free survival. Differential tumor-cell surface expression makes CEACAM6 a promising biomarker, supporting a review of its roles, signaling pathways, and CEACAM6-targeted therapies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ceacam6-expression-and-function-in-tumor-biology-a-comprehensive-review/341248/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ceacam6-expression-and-function-in-tumor-biology-a-comprehensive-review/341248.png","ImageObject",300,407,{"name":92,"@type":93},"Hazel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is CEACAM6 and where is it primarily expressed?","Question",{"text":112,"@type":113},"CEACAM6 is an immunoglobulin superfamily protein primarily expressed on epithelial surfaces and myeloid cells.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does CEACAM6 contribute to cancer progression?",{"text":117,"@type":113},"CEACAM6 promotes tumor progression by inhibiting apoptosis, enhancing drug resistance, and facilitating invasion and metastasis.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is CEACAM6 considered a promising cancer biomarker?",{"text":121,"@type":113},"CEACAM6 shows differential expression on tumor cell surfaces, and its elevated levels are generally linked to poorer prognosis, supporting its use for diagnosis and stratification.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},341248,1790160156,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","Review  \nCEACAM6 expression and function in tumor biology: a comprehensive review  \nDong Zhao1 · Fei Cai1,2 · Xuefei Liu1 · Tingting Li1 · Ershu Zhao1 · Xinlong Wang1 · Zhendong Zheng1  \nReceived: 10 January 2024 / Accepted: 22 May 2024  \n© The Author(s) 2024 OPEN  \nAbstract  \nCarcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) is an immunoglobulin superfamily protein primarily expressed on epithelial surfaces and myeloid cells. It plays a significant role in cancer progression by inhibiting apoptosis, promoting drug resistance, and facilitating cancer cell invasion and metastasis. Overexpression of CEACAM6 has been observed in various cancers, including lung, breast, colorectal, and hepatocellular cancers, and is associated with poorer overall survival and disease-free survival. Its differential expression on tumor cell surfaces makes it a promising cancer marker. This review aims to provide a comprehensive summary of CEACAM6’s role in different cancer types, its involvement in signaling pathways, and recent advancements in CEACAM6-targeted treatments.  \nKeywords CEACAM6 · TME · Biomarkers · Therapeutic target · Vaccine therapy  \n1 Introduction  \nThe CEA family was first described over 50 years ago [1, 2]. It was initially identified in primary and metastatic colorectal cancer, as dysregulation of CEACAM6 is the earliest molecular change observed in proliferative colon polyps and early adenomas [3, 4]. Subsequently, CEAs were found in various cancerous tissues and fetal tissues, and were found to have tumor-related immune functions inT cells, NK cells, and neutrophils [5, 6]. CEACAM6, also known as CD66c or NCA-90, is a non-specific cross-reactive glycoprotein antigen that shares some antigenic determinants with the family member CEACAM5 [7] . Both CEACAM5 and CEACAM6 are tumor-associated antigens that play important roles in cell adhesion and tumor cytochemical sensitivity. While CEACAM5 has received more attention, recent studies suggest that CEACAM6 may be a more promising target for antibody-based anti-metastasis and chemical sensitization therapy [8, 9]. This is due to the higher expression of CEACAM6 in cancer, as well as its correlation with prognostic indicators such as disease-free survival (DFS) and overall survival (OS) [10]. Among various cancer types, pancreatic cancer has been extensively studied in terms ofCEACAM6 expression [11]. Differentially expressed proteins on the cell membrane surface, such as CEACAM6, are attractive therapeutic targets. As an important pathological biomarker in cancer, targeting CEACAM6 or the signaling pathway mediated by CEACAM6 has garnered significant attention in recent years.  \nDong Zhao and Fei Cai have contributed equally to this work.  \n* Zhendong Zheng, [gcp_zzd@sina.com](gcp_zzd@sina.com); Dong Zhao, [johndoon@126.com](johndoon@126.com); Fei Cai, [18903862643@163.com](18903862643@163.com); Xuefei Liu, [feiliu6@163.com](feiliu6@163.com);  \nTingting Li, [tingting870519@163.com](tingting870519@163.com); Ershu Zhao, [843643250@qq.com](843643250@qq.com); Xinlong Wang, [15225970555@163.com |](15225970555@163.com |1Department)[1](15225970555@163.com |1Department)[Department](15225970555@163.com |1Department)  \n[of Oncology](of Oncology), [General Hospital of Northern Theater Command](General Hospital of Northern Theater Command), [Shenyang](Shenyang), [China](China). 2China Medical University, Shenyang, China.  \nDiscover Oncology  \n(2024) 15:186  \n| [https://doi.org/10.1007/s12672-024-01053-6](https://doi.org/10.1007/s12672-024-01053-6)  \n2 CEACAM6 and biomarker  \nBiomarkers are measurable indicators of exposure to normal and pathological processes or interventions. With the introduction of precision medicine, there is an increasing demand for biomarkers that can aid in early cancer detection, stratification, and personalized treatment. An ideal cancer biomarker should possess the following characteristics: (1) specific membrane expression in tumor cells, allowing f","cbCaibho9V2uEjsG","https://ap.wps.com/l/cbCaibho9V2uEjsG","pdf",684604,"English","# Abstract\n# 1 Introduction\n# 2 CEACAM6 and biomarker","[{\"question\":\"What is CEACAM6 and where is it primarily expressed?\",\"answer\":\"CEACAM6 is an immunoglobulin superfamily protein primarily expressed on epithelial surfaces and myeloid cells.\"},{\"question\":\"How does CEACAM6 contribute to cancer progression?\",\"answer\":\"CEACAM6 promotes tumor progression by inhibiting apoptosis, enhancing drug resistance, and facilitating invasion and metastasis.\"},{\"question\":\"Why is CEACAM6 considered a promising cancer biomarker?\",\"answer\":\"CEACAM6 shows differential expression on tumor cell surfaces, and its elevated levels are generally linked to poorer prognosis, supporting its use for diagnosis and stratification.\"}]","CEACAM6 expression and function in tumor biology - a comprehensive review | PDF",1790041114,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8dfb5b91c478ca3a39dfa2051f3dceca.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7e33af0565545cc6a293b23c739bc1c5.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/03865eab70b544659752a0b4a0f92a4f.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/00e8a75d382f6936ebb5c84130cd435f.webp",980,1301]